Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Analysis of Inventory

Microsoft Excel

Inventory Disclosure

Bristol-Myers Squibb Co., balance sheet: inventory

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Finished goods 663 509 543 932 2,227
Work in process 2,430 1,850 2,111 2,015 3,267
Raw and packaging materials 475 464 350 207 172
Inventories 3,568 2,823 3,004 3,154 5,666

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Item Description The company
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Bristol-Myers Squibb Co. inventories decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.